查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087621

移植診斷市場：依診斷應用、技術、器官類型和最終用戶分類－2026-2032年全球市場預測

Transplant Diagnostics Market by Diagnostic Application, Technology, Organ Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，移植診斷市場將成長至 109.2 億美元，複合年成長率為 7.03%。

主要市場統計數據
基準年 2025 67.8億美元
預計年份：2026年 72億美元
預測年份 2032 109.2億美元
複合年成長率 (%) 7.03%

移植診斷市場簡介

移植診斷是精準醫學的關鍵領域，它能夠實現更安全的器官分配、供受者相容性評估、免疫風險分層和移植後監測。此領域包括人類白血球抗原（HLA）分型、抗體篩檢、交叉配對試驗、嵌合體檢測和傳染病檢查，以及次世代定序（NGS）、數位PCR和捐贈者來源的遊離DNA（cfDNA）檢測等新型分子診斷工具。

移植診斷的變革性變化

移植診斷領域正從傳統的以血清學檢測為中心的檢測方法轉向整合分子生物學、免疫學和數據分析的綜合工作流程。許多先進的檢查室正在從低解析度的HLA型檢測轉向高解析度的NGS技術，後者能夠提高等位基因水平的特徵分析能力，使臨床醫生能夠更準確地識別免疫風險。

人工智慧（AI）的累積影響

在移植診斷領域，隨著HLA定序、抗體譜分析、病歷、供體觀察、病理學發現、影像學檢查以及移植時間序列監測等產生的複雜高維度資料不斷湧現，人工智慧（AI）的重要性日益凸顯。 AI驅動的分析能夠快速評估免疫風險，提高抗體資料模式識別能力，並幫助移植團隊優先處理具有臨床意義的觀察。

關鍵區域洞察：全球移植診斷需求

北美憑藉其完善的器官分配系統、先進的組織學相容性檢查室、針對專業分子檢測的保險報銷機制以及廣泛的臨床研究活動，仍然是移植診斷領域的領先地區。美國憑藉其由器官移植網路（OPTN）管理的分配系統、龐大的移植數量以及HLA型檢測、抗體檢測、交叉配對試驗和分子監測技術的廣泛應用，在該領域擁有尤為顯著的影響力。另一方面，加拿大則受益於其協調的公共移植服務和檢查室品管系統。

對關鍵組織集團的洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團與北約

在東協地區，三級醫療機構的擴張、部分市場的醫療旅遊以及對HLA型檢測、交叉配對試驗、抗體篩檢和傳染病檢查能力的逐步投資，正在塑造對移植診斷的需求。海灣合作理事會（GCC）國家憑藉其先進的醫療基礎設施、國家移植計畫和專業檢查室，正優先發展高品質的免疫遺傳學、分子診斷和移植後監測服務。

對主要移植診斷市場關鍵國家的洞察

美國憑藉著積極的移植活動、完善的檢查室基礎設施以及廣泛應用HLA型檢測、抗體鑑定、虛擬交叉配對試驗和移植後監測等技術，在移植診斷領域處於領先地位。加拿大擁有強大的公共醫療合作夥伴關係和先進的移植項目，而墨西哥則透過國家和地區層面的移植舉措擴大移植服務覆蓋範圍。巴西擁有拉丁美洲規模最大的移植系統，這得益於其完善的公共器官捐贈和移植體係以及日益成長的組織相容性檢測需求。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的端到端移植診斷方案，該方案應整合移植前相容性評估、移植前後風險評估以及移植後後續觀察。將HLA型檢測、抗體檢測、分子監測、自動化和數據解讀相結合的供應商將更有能力為尋求可操作結果而非孤立檢測結果的移植中心提供支援。

調查方法

本執行摘要採用結構化的二手資料研究途徑，並整合了專家見解。檢驗資訊來源包括全球捐贈與移植觀察站提供的公開移植活動數據、世界衛生組織相關報告、器官移植網路（OPTN）和衛生資源和服務管理局（HRSA）資源、國家移植機構、同行評審的移植期刊、監管指南以及公開的醫療保健系統資訊披露。

結論：精準診斷對於決定移植結果至關重要。

移植診斷市場正從孤立的相容性檢測發展成為更廣泛、更複雜的移植管理生態系統。不斷成長的移植需求、持續的器官短缺、日益複雜的免疫學以及提高移植存活率的需求，都進一步提升了先進診斷技術的戰略價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 移植診斷市場：依診斷應用分類

  • 供受者匹配
  • 移植監測
  • HLA型檢測
    • 高解析度
    • 低解析度
  • 傳染病篩檢
    • 細菌篩檢
    • 真菌篩檢
    • 病毒篩檢
      • 巨細胞病毒
      • EB病毒
      • 肝炎病毒
      • HIV

第8章 移植診斷市場：依技術分類

  • 酵素法
  • 流式細胞技術
  • PCR
    • 數位PCR
    • qPCR
  • 定序
    • 新一代
    • 桑格法

第9章 移植診斷市場：依器官類型分類

  • 心
  • 腎
  • 肝
  • 肺
  • 胰臟

第10章 移植診斷市場：依最終使用者分類

  • 診斷檢查室
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究機構
  • 移植中心

第11章 移植診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 移植診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 移植診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • altona Diagnostics GmbH
  • Arquer Diagnostics Ltd.
  • BAG Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMerieux SA
  • Bruker Corporation
  • Caredx Inc.
  • CareDx, Inc.
  • CLONIT srl
  • Diagnostica Longwood SL
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics BV
  • Hologic, Inc.
  • Illumina, Inc
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Novartis AG
  • PathoNostics BV
  • QIAGEN, NV
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Zimmer Biomet Group
Product Code: MRR-031685195790

The Transplant Diagnostics Market is projected to grow by USD 10.92 billion at a CAGR of 7.03% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.78 billion
Estimated Year [2026] USD 7.20 billion
Forecast Year [2032] USD 10.92 billion
CAGR (%) 7.03%

Transplant Diagnostics Market Introduction

Transplant diagnostics is a mission-critical segment of precision medicine, enabling safer organ allocation, donor-recipient compatibility assessment, immune risk stratification, and post-transplant monitoring. The field spans human leukocyte antigen (HLA) typing, antibody screening, crossmatching, chimerism testing, infectious disease testing, and emerging molecular tools such as next-generation sequencing (NGS), digital PCR, and donor-derived cell-free DNA assays.

Demand is anchored in measurable clinical need. The Global Observatory on Donation and Transplantation, supported by the World Health Organization and Organizacion Nacional de Trasplantes, reported more than 157,000 solid organ transplants worldwide in 2022, with kidney transplantation representing the largest procedure category. In the United States, the Health Resources and Services Administration and OPTN data consistently show more than 100,000 people on the national transplant waiting list, underscoring the persistent need for accurate transplant diagnostics that improve matching, reduce rejection risk, and support long-term graft survival.

Transformative Shifts in Transplant Diagnostics

The transplant diagnostics landscape is shifting from conventional serology-led testing toward integrated molecular, immunologic, and data-enabled workflows. HLA typing has moved from lower-resolution methods to high-resolution NGS in many advanced laboratories, improving allele-level characterization and helping clinicians identify immunologic risk with greater precision.

At the same time, transplant programs are expanding beyond pre-transplant compatibility testing. Post-transplant surveillance is gaining strategic importance as clinicians seek earlier signals of antibody-mediated rejection, cellular rejection, infection, and graft injury. Donor-derived cell-free DNA testing, noninvasive biomarker panels, and more standardized antibody monitoring are changing how laboratories, transplant centers, and diagnostics providers define value across the full transplant care continuum.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly relevant to transplant diagnostics because the field generates complex, high-dimensional data from HLA sequencing, antibody profiles, clinical histories, donor characteristics, pathology, imaging, and longitudinal graft monitoring. AI-enabled analytics can support faster interpretation of immunologic risk, improve pattern recognition in antibody data, and help prioritize clinically meaningful findings for transplant teams.

The cumulative impact of AI is expected to be operational as much as scientific. Laboratories can use machine learning-supported quality control, workflow triage, and decision-support tools to reduce manual review burden and improve turnaround time. However, adoption depends on transparent model validation, bias assessment, clinical governance, regulatory compliance, and interoperability with laboratory information systems and electronic health records.

Key Regional Insights: Global Transplant Diagnostics Demand

North America remains a leading region for transplant diagnostics due to established organ allocation infrastructure, advanced histocompatibility laboratories, reimbursement pathways for specialized molecular testing, and extensive clinical research activity. The United States is particularly influential through OPTN-governed allocation systems, large transplant volumes, and broad adoption of HLA typing, antibody testing, crossmatching, and molecular monitoring technologies, while Canada benefits from coordinated public transplant services and laboratory quality systems.

Europe benefits from mature transplant networks, national donation agencies, and cross-border collaboration, including Eurotransplant and national systems in the United Kingdom, Germany, France, Spain, and Italy. Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia increase transplant capacity, improve laboratory accreditation, and invest in molecular diagnostics. Latin America, led by Brazil and Mexico, shows rising demand supported by public transplant programs, though access and funding remain uneven across health systems. The Middle East, especially GCC countries, is investing in tertiary care, organ donation frameworks, and transplant infrastructure, while Africa remains an emerging opportunity where diagnostic access, trained personnel, laboratory networks, and deceased donation systems are still developing.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, transplant diagnostics demand is shaped by expanding tertiary hospitals, medical tourism in selected markets, and gradual investment in HLA typing, crossmatching, antibody screening, and infectious disease testing capabilities. The GCC is prioritizing advanced healthcare infrastructure, national transplant programs, and specialized laboratories, creating demand for high-quality immunogenetics, molecular diagnostics, and post-transplant monitoring services.

The European Union offers a strong regulatory and clinical environment for validated transplant testing, supported by harmonized quality expectations, mature donation systems, and cross-border clinical collaboration. BRICS countries represent a strategically important group because of large patient populations, rising chronic kidney disease burden, and investment in transplant capacity, although reimbursement, accreditation, and diagnostic access vary widely. G7 countries lead in technology adoption, clinical research, automation, NGS-based HLA typing, and noninvasive graft monitoring, while NATO member states overlap significantly with advanced healthcare systems that rely on resilient diagnostics supply chains, standardized laboratory practices, and interoperable transplant data systems.

Key Country Insights Across Major Transplant Diagnostics Markets

The United States leads transplant diagnostics adoption through high transplant activity, strong laboratory infrastructure, and broad use of HLA typing, antibody identification, virtual crossmatching, and post-transplant monitoring. Canada maintains strong public healthcare coordination and advanced transplant programs, while Mexico is expanding access through national and regional transplant initiatives. Brazil is Latin America's largest transplant system by procedural scale, supported by a public donation and transplant framework and growing demand for histocompatibility testing.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are core markets due to organized donation systems, high clinical standards, and established histocompatibility laboratories; Spain is especially recognized for its world-leading deceased donation model. Russia has specialized transplant capabilities but faces uneven regional access and infrastructure variability. In Asia-Pacific, China and India offer significant long-term expansion potential due to population scale, chronic kidney disease burden, and increasing transplant capacity; Japan has sophisticated diagnostics adoption within a highly regulated system, Australia maintains advanced transplant services and national coordination, and South Korea combines strong hospital infrastructure with rapid molecular diagnostics uptake.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated, end-to-end transplant diagnostics portfolios that connect pre-transplant compatibility, peri-transplant risk assessment, and post-transplant surveillance. Providers that combine HLA typing, antibody testing, molecular monitoring, automation, and data interpretation will be better positioned to support transplant centers seeking actionable results rather than isolated test outputs.

Strategic priorities include expanding NGS-based HLA capabilities, strengthening evidence for donor-derived cell-free DNA and other noninvasive biomarkers, improving laboratory workflow automation, and building interoperable software for longitudinal patient monitoring. Organizations should also invest in regional access strategies, distributor quality management, clinical education, and partnerships with transplant networks to demonstrate outcomes such as reduced rejection risk, improved graft monitoring, and faster decision-making.

Research Methodology

This executive summary is developed using a structured secondary research approach and expert synthesis. Verified sources include public transplant activity data from the Global Observatory on Donation and Transplantation, WHO-associated reporting, OPTN and HRSA resources, national transplant agencies, peer-reviewed transplantation journals, regulatory guidance, and publicly available healthcare system disclosures.

The methodology emphasizes data triangulation across procedure volumes, diagnostic adoption patterns, clinical guidelines, technology trends, reimbursement signals, and regional healthcare infrastructure. Insights were assessed for consistency, recency, and relevance to transplant diagnostics, with emphasis on evidence-backed developments in HLA typing, antibody monitoring, crossmatching, molecular diagnostics, noninvasive graft surveillance, and AI-enabled laboratory workflows.

Conclusion: Precision Diagnostics Will Define Transplant Outcomes

The transplant diagnostics market is evolving from episodic compatibility testing into a broader precision transplant management ecosystem. Rising transplant demand, persistent organ shortages, increasing immunologic complexity, and the need for improved graft survival are reinforcing the strategic value of advanced diagnostics.

Organizations that deliver validated molecular tools, faster laboratory workflows, integrated data interpretation, and clinically meaningful surveillance solutions are positioned to strengthen competitive relevance. As healthcare systems focus on measurable outcomes, transplant diagnostics will remain essential to organ allocation, rejection prevention, patient monitoring, and long-term transplant success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transplant Diagnostics Market, by Diagnostic Application

  • 7.1. Donor Recipient Matching
  • 7.2. Graft Monitoring
  • 7.3. Hla Typing
    • 7.3.1. High Resolution
    • 7.3.2. Low Resolution
  • 7.4. Infectious Disease Screening
    • 7.4.1. Bacterial Screening
    • 7.4.2. Fungal Screening
    • 7.4.3. Viral Screening
      • 7.4.3.1. Cytomegalovirus
      • 7.4.3.2. Epstein Barr Virus
      • 7.4.3.3. Hepatitis Viruses
      • 7.4.3.4. Hiv

8. Transplant Diagnostics Market, by Technology

  • 8.1. Enzymatic Assays
  • 8.2. Flow Cytometry
  • 8.3. Pcr
    • 8.3.1. Digital Pcr
    • 8.3.2. Qpcr
  • 8.4. Sequencing
    • 8.4.1. Next Generation
    • 8.4.2. Sanger

9. Transplant Diagnostics Market, by Organ Type

  • 9.1. Heart
  • 9.2. Kidney
  • 9.3. Liver
  • 9.4. Lung
  • 9.5. Pancreas

10. Transplant Diagnostics Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Research Institutes
  • 10.4. Transplant Centers

11. Transplant Diagnostics Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Transplant Diagnostics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Transplant Diagnostics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Adaptive Biotechnologies Corporation
  • 15.3. altona Diagnostics GmbH
  • 15.4. Arquer Diagnostics Ltd.
  • 15.5. BAG Group
  • 15.6. Becton, Dickinson and Company
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Biogenuix Medsystems Pvt. Ltd
  • 15.9. BioMerieux SA
  • 15.10. Bruker Corporation
  • 15.11. Caredx Inc.
  • 15.12. CareDx, Inc.
  • 15.13. CLONIT srl
  • 15.14. Diagnostica Longwood SL
  • 15.15. DiaSorin S.p.A.
  • 15.16. Eurofins Scientific SE
  • 15.17. F. Hoffmann-La Roche Ltd.
  • 15.18. Genome Diagnostics B.V.
  • 15.19. Hologic, Inc.
  • 15.20. Illumina, Inc
  • 15.21. Immucor, Inc.
  • 15.22. Laboratory Corporation of America Holdings
  • 15.23. Luminex Corporation
  • 15.24. Merck KGaA
  • 15.25. NanoString Technologies, Inc.
  • 15.26. Novartis AG
  • 15.27. PathoNostics B.V
  • 15.28. QIAGEN, N.V.
  • 15.29. Quest Diagnostics Incorporated
  • 15.30. Randox Laboratories Ltd.
  • 15.31. Takara Bio Inc.
  • 15.32. Thermo Fisher Scientific Inc.
  • 15.33. TransMedics, Inc.
  • 15.34. Zimmer Biomet Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DONOR RECIPIENT MATCHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DONOR RECIPIENT MATCHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DONOR RECIPIENT MATCHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GRAFT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GRAFT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GRAFT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HLA TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HLA TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HLA TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOW RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOW RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOW RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FUNGAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FUNGAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FUNGAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIRAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIRAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIRAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CYTOMEGALOVIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CYTOMEGALOVIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CYTOMEGALOVIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EPSTEIN BARR VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EPSTEIN BARR VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EPSTEIN BARR VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEPATITIS VIRUSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEPATITIS VIRUSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEPATITIS VIRUSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIV MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIV MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIV MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENZYMATIC ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL QPCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL QPCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL QPCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEXT GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEXT GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEXT GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SANGER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SANGER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SANGER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LUNG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LUNG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LUNG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 184. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 185. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 186. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 188. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 189. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 217. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 218. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 219. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 221. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 222. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 228. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 229. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 230. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 232. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 233. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 344. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 346. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY VIRAL SCREENING, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 353. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 354. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 355. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 357. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 358. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 359. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 360. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, 2018-2032 (USD MILLION)
  • TABLE 361. INDIA TRANSPLANT DIAGNOSTICS